Clinical Trials Logo

Clinical Trial Summary

Participants who meet the eligibility criteria and who consent to participation or whose parents/legal guardian consent to their participation, will be enrolled in the study for a period of up to 14 days. Enrolment visit (Day 1) assessments for all participants will include the collection of throat swabs, testing by staff at the site using the ellume·lab Group A Strep Test and testing for Group A Streptococcus by a central laboratory using bacterial culture and polymerase chain reaction (PCR). All participants will be followed up with a phone assessment of adverse events between Days 2-14.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03171350
Study type Interventional
Source Ellume Pty Ltd
Contact
Status Completed
Phase N/A
Start date May 24, 2017
Completion date August 15, 2018

See also
  Status Clinical Trial Phase
Withdrawn NCT03693495 - Performance of Ellume·Lab Group A Strep Test Versus Culture for the Rapid Detection of Group A Streptococcus in Participants With Acute Pharyngitis N/A
Recruiting NCT04882514 - A Trial of a Peptide-based Group A Streptococcal (GAS) Vaccine Candidate in Healthy Individuals. Phase 1/Phase 2
Completed NCT01979588 - How Does the Clinical Tool 'What's Going Around' Affect Clinical Practice N/A
Completed NCT05117528 - Streptococcus Pyogenes Carriage Acquisition and Transmission Study
Completed NCT03361163 - Controlled Human Infection for Vaccination Against Streptococcus Pyogenes Phase 1
Completed NCT03777098 - Pilot Study of Strepic® Device for the Diagnosis of Group A Streptococcal Pharyngitis
Recruiting NCT05175196 - CandyCollect Strep Throat Testing N/A